Associations of statin adherence and lipid targets with adverse outcomes in myocardial infarction survivors: a retrospective cohort study
Open Access
Abstract
Objectives To examine associations between statin adherence and lipid target achievement in myocardial infarction (MI) survivors, and their associations with mortality and recurrent MIs. Design Retrospective cohort study using linked clinical records within the National Health Service Greater Glasgow and Clyde (NHS GGC) Data Safe Haven. Setting Routine clinical practice in the NHS GGC area between January 2009 and July 2017. Participants Patients ≥18 years who experienced a non-fatal MI hospital admission (ICD10: I21, I22) between January 2009 and July 2014 (n=11 031), followed up from the date of MI admission until July 2017 or death, whichever occurred first. Primary and secondary outcome measures Statin adherence was estimated using encashed prescriptions and lipid results from routine biochemistry data. Primary lipid and statin adherence targets were LDL ≤1.8 mmol/L and adherence ≥50%, and were related to all-cause death, deaths due to cardiovascular disease (CVD) (ICD10: I00–I99 as the underlying cause), and recurrent MI in unadjusted models and models adjusting for age, sex, socioeconomic deprivation and year of MI. Results Over 4.5 years follow-up, 76% achieved LDL ≤1.8 mmol/L, and 84.5% had average adherence ≥50%. Patients with adherence Conclusions Non-achievement of lipid and adherence targets are associated with increased risks of all-cause and CVD mortality. Further work is required to optimise their use to improve outcomes in clinical practice.Keywords
Funding Information
- Medical Research Council (MR/N013166/1)
This publication has 22 references indexed in Scilit:
- 2016 European Guidelines on cardiovascular disease prevention in clinical practiceEuropean Heart Journal, 2016
- LDL cholesterol response and statin adherence among high-risk patients initiating treatment.2016
- The impact of time-window bias on the assessment of the long-term effect of medication adherence: the case of secondary prevention after myocardial infarctionBMJ Open, 2015
- Data Resource Profile: Clinical Practice Research Datalink (CPRD)International Journal of Epidemiology, 2015
- Statins2015
- Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequencesEuropean Heart Journal, 2013
- Standardizing Terminology and Definitions of Medication Adherence and Persistence in Research Employing Electronic DatabasesMedical Care, 2013
- Adherence to Drugs That Prevent Cardiovascular Disease: Meta-analysis on 376,162 PatientsThe American Journal of Medicine, 2012
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trialsThe Lancet, 2010
- Good and poor adherence: optimal cut-point for adherence measures using administrative claims dataCurrent Medical Research and Opinion, 2009